Ning Shan

Ning Shan

Chief Scientific Officer @ Aclipse Therapeutics

About

I am an experienced pharmaceutical scientist with a PhD in Chemistry and has a robust working knowledge in small molecule drug development. I have a deep understanding of pharmaceutical science, current industry best practices, and regulatory requirements. My expertise focuses on preclinical and clinical-stage CMC development, with a span of cross-function pharmaceutical development, preformulation, formulation, drug delivery, regulatory affairs, IP protection, and business development. I have been involved in strategic planning of pharmaceutical development and intellectual property protection. I have been managing a number of small molecule projects from preclinical stage to Phase 1/2/3. I was a key CMC member to support FDA NDA approval of Syndros® for commercialization. I am a renowned subject matter expert in organic solid-state chemistry, with a special focus on pharmaceutical solid forms and formulations. I invented the innovative “solvent-drop grinding” technology for solid form screening. As a prominent scientist, I have been continuously involved in academic activities, serving as an adjunct professor and supervising and teaching at several universities (NUS, USF, UPacific). I have authored 35 peer-reviewed journal publications with over 5000 citations (h-index: 27) and hold more than 50 issued and pending patents.

Country

United States

City

Chandler

Industry

Pharmaceuticals

Skill

Chemistry, Manufacturing, and Controls (CMC), Preformulation, Formulation, GMP, Drug Delivery, Drug Discovery, CRO Management, Project Management, Cross-functional Team Leadership, Translational Research, Crystal form, Computational Chemistry, Programming, Python (Programming Language), Java, Chemical Analysis, Pharmaceuticals, Preclinical development, GLP, Chemistry

Experience

Aclipse Therapeutics

Chief Scientific Officer

Aclipse Therapeutics

LinkedIn
2018 - Present · 8 yrs

King of Prussia, PA

• Lead CMC product development (preformulation and formulation) to support preclinical and clinical development • Manage CMC regulatory filings (pre-IND/IND/CTN/orphan designation) and communications with US FDA and other regulatory authorities • Support cross-function project management (DMPK, toxicology, regulatory, clinical) to support drug development • Support business and drug development activities; strong technical R&D experience along with business development and licensing/collaboration experience to support internal development

Insys Therapeutics, Inc.

Senior Manager, Formulation

Insys Therapeutics, Inc.

2015 - 2018 · 3 yrs

Chandler, AZ

• CMC development from preclinical stage to NDA (oral, buccal, sublingual, intranasal) • Development and life cycle management of small molecule and combination drug products • Key CMC team member to support the FDA NDA approval of Syndros® • Managed CROs for GMP manufacturing to support IND filing and clinical studies • Support external preclinical DMPK studies for formulation development • Authored and reviewed scientific reports, regulatory filings and patent applications • Key technical person for R&D project evaluation and in-licensing opportunities • Supervised a group of 8 PhD/MSc/BSc level formulation and analytical scientists

Thar Pharmaceuticals Inc (Grünenthal Pharma GmbH)

Director, Pharmaceutical Development / Sr Scientist

Thar Pharmaceuticals Inc (Grünenthal Pharma GmbH)

2007 - 2015 · 8 yrs

Tampa/St. Petersburg, Florida Area

• Small molecule preformulation and formulation development (indications: oncology, pain, CNS, antibiotics) from preclinical to Phase 1/2/3 • Managed external cGMP manufacturing and analytical development • Developed Thar’s propitiatory ENHANCE™ technology for solubility and permeability enhancement of small molecule drugs • Prepared and reviewed CMC scientific reports, patent application and documents for regulatory filings. Support overall corporate IP protection activities and fund raising • Supported preclinical in vivo studies (PKPD, tox). • Scientific lead to support project selection, potential scientific goal setting, and budgets and produce development planning • Mentored and supervised PhD/BSc-level research scientists

Thar Pharmaceuticals Inc (Grünenthal Pharma GmbH)

Sr Scientist

Thar Pharmaceuticals Inc (Grünenthal Pharma GmbH)

2007 - 2010 · 3 yrs

Tampa/St. Petersburg, Florida Area

Institute of Chemical and Engineering Sciences

Postdoctoral Research Fellow

Institute of Chemical and Engineering Sciences

2003 - 2006 · 3 yrs
Massachusetts Institute of Technology

Visiting Scientist

Massachusetts Institute of Technology

LinkedIn
2004 - 2005 · 1 yr

Cambridge, Massachusetts

• Computer modeling with multiple languages to set up and simulate systems involving amino acids, peptides and proteins • Data analysis and presentation of findings to the research team • Development of software tools to automate data analysis processes

Education

University of Cambridge

University of Cambridge

LinkedIn

Physical Chemistry

2000 - 2003 · 3 yrs
Wuhan University

Wuhan University

LinkedIn

Chemistry

1996 - 2000 · 4 yrs

Ning Shan's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.